The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetic Shoes Market Research Report 2024
Synopsis
The global Diabetic Shoes market was valued at US$ 2023.2 million in 2023 and is anticipated to reach US$ 3034.2 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetic Shoes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Shoes.
Report Scope
The Diabetic Shoes market size, estimations, and forecasts are provided in terms of sales volume (K Pairs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Shoes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Shoes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aetrex
Drew Shoe
Dr. Comfort
Skechers
Rockport
Reebok
Orthafeet
New Balance
P.w.minor
Apis
Apex
Dr. Zen
Segment by Type
Diabetic Dress & Casual Shoes
Diabetic Work Shoes
Diabetic Walking Shoes
Others (Sandals, Clogs, etc.)
Segment by Application
Women
Men
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetic Shoes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetic Shoes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Diabetic Shoes market was valued at US$ 2023.2 million in 2023 and is anticipated to reach US$ 3034.2 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetic Shoes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Shoes.
Report Scope
The Diabetic Shoes market size, estimations, and forecasts are provided in terms of sales volume (K Pairs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Shoes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Shoes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aetrex
Drew Shoe
Dr. Comfort
Skechers
Rockport
Reebok
Orthafeet
New Balance
P.w.minor
Apis
Apex
Dr. Zen
Segment by Type
Diabetic Dress & Casual Shoes
Diabetic Work Shoes
Diabetic Walking Shoes
Others (Sandals, Clogs, etc.)
Segment by Application
Women
Men
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetic Shoes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetic Shoes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diabetic Shoes Market Overview
1.1 Product Overview and Scope of Diabetic Shoes
1.2 Diabetic Shoes Segment by Type
1.2.1 Global Diabetic Shoes Market Value Comparison by Type (2024-2030)
1.2.2 Diabetic Dress & Casual Shoes
1.2.3 Diabetic Work Shoes
1.2.4 Diabetic Walking Shoes
1.2.5 Others (Sandals, Clogs, etc.)
1.3 Diabetic Shoes Segment by Application
1.3.1 Global Diabetic Shoes Market Value by Application: (2024-2030)
1.3.2 Women
1.3.3 Men
1.4 Global Diabetic Shoes Market Size Estimates and Forecasts
1.4.1 Global Diabetic Shoes Revenue 2019-2030
1.4.2 Global Diabetic Shoes Sales 2019-2030
1.4.3 Global Diabetic Shoes Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diabetic Shoes Market Competition by Manufacturers
2.1 Global Diabetic Shoes Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diabetic Shoes Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diabetic Shoes Average Price by Manufacturers (2019-2024)
2.4 Global Diabetic Shoes Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetic Shoes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetic Shoes, Product Type & Application
2.7 Diabetic Shoes Market Competitive Situation and Trends
2.7.1 Diabetic Shoes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetic Shoes Players Market Share by Revenue
2.7.3 Global Diabetic Shoes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetic Shoes Retrospective Market Scenario by Region
3.1 Global Diabetic Shoes Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diabetic Shoes Global Diabetic Shoes Sales by Region: 2019-2030
3.2.1 Global Diabetic Shoes Sales by Region: 2019-2024
3.2.2 Global Diabetic Shoes Sales by Region: 2025-2030
3.3 Global Diabetic Shoes Global Diabetic Shoes Revenue by Region: 2019-2030
3.3.1 Global Diabetic Shoes Revenue by Region: 2019-2024
3.3.2 Global Diabetic Shoes Revenue by Region: 2025-2030
3.4 North America Diabetic Shoes Market Facts & Figures by Country
3.4.1 North America Diabetic Shoes Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diabetic Shoes Sales by Country (2019-2030)
3.4.3 North America Diabetic Shoes Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diabetic Shoes Market Facts & Figures by Country
3.5.1 Europe Diabetic Shoes Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diabetic Shoes Sales by Country (2019-2030)
3.5.3 Europe Diabetic Shoes Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetic Shoes Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetic Shoes Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diabetic Shoes Sales by Country (2019-2030)
3.6.3 Asia Pacific Diabetic Shoes Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diabetic Shoes Market Facts & Figures by Country
3.7.1 Latin America Diabetic Shoes Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diabetic Shoes Sales by Country (2019-2030)
3.7.3 Latin America Diabetic Shoes Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetic Shoes Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetic Shoes Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diabetic Shoes Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diabetic Shoes Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diabetic Shoes Sales by Type (2019-2030)
4.1.1 Global Diabetic Shoes Sales by Type (2019-2024)
4.1.2 Global Diabetic Shoes Sales by Type (2025-2030)
4.1.3 Global Diabetic Shoes Sales Market Share by Type (2019-2030)
4.2 Global Diabetic Shoes Revenue by Type (2019-2030)
4.2.1 Global Diabetic Shoes Revenue by Type (2019-2024)
4.2.2 Global Diabetic Shoes Revenue by Type (2025-2030)
4.2.3 Global Diabetic Shoes Revenue Market Share by Type (2019-2030)
4.3 Global Diabetic Shoes Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diabetic Shoes Sales by Application (2019-2030)
5.1.1 Global Diabetic Shoes Sales by Application (2019-2024)
5.1.2 Global Diabetic Shoes Sales by Application (2025-2030)
5.1.3 Global Diabetic Shoes Sales Market Share by Application (2019-2030)
5.2 Global Diabetic Shoes Revenue by Application (2019-2030)
5.2.1 Global Diabetic Shoes Revenue by Application (2019-2024)
5.2.2 Global Diabetic Shoes Revenue by Application (2025-2030)
5.2.3 Global Diabetic Shoes Revenue Market Share by Application (2019-2030)
5.3 Global Diabetic Shoes Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Aetrex
6.1.1 Aetrex Corporation Information
6.1.2 Aetrex Description and Business Overview
6.1.3 Aetrex Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Aetrex Diabetic Shoes Product Portfolio
6.1.5 Aetrex Recent Developments/Updates
6.2 Drew Shoe
6.2.1 Drew Shoe Corporation Information
6.2.2 Drew Shoe Description and Business Overview
6.2.3 Drew Shoe Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Drew Shoe Diabetic Shoes Product Portfolio
6.2.5 Drew Shoe Recent Developments/Updates
6.3 Dr. Comfort
6.3.1 Dr. Comfort Corporation Information
6.3.2 Dr. Comfort Description and Business Overview
6.3.3 Dr. Comfort Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Comfort Diabetic Shoes Product Portfolio
6.3.5 Dr. Comfort Recent Developments/Updates
6.4 Skechers
6.4.1 Skechers Corporation Information
6.4.2 Skechers Description and Business Overview
6.4.3 Skechers Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Skechers Diabetic Shoes Product Portfolio
6.4.5 Skechers Recent Developments/Updates
6.5 Rockport
6.5.1 Rockport Corporation Information
6.5.2 Rockport Description and Business Overview
6.5.3 Rockport Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Rockport Diabetic Shoes Product Portfolio
6.5.5 Rockport Recent Developments/Updates
6.6 Reebok
6.6.1 Reebok Corporation Information
6.6.2 Reebok Description and Business Overview
6.6.3 Reebok Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Reebok Diabetic Shoes Product Portfolio
6.6.5 Reebok Recent Developments/Updates
6.7 Orthafeet
6.6.1 Orthafeet Corporation Information
6.6.2 Orthafeet Description and Business Overview
6.6.3 Orthafeet Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Orthafeet Diabetic Shoes Product Portfolio
6.7.5 Orthafeet Recent Developments/Updates
6.8 New Balance
6.8.1 New Balance Corporation Information
6.8.2 New Balance Description and Business Overview
6.8.3 New Balance Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.8.4 New Balance Diabetic Shoes Product Portfolio
6.8.5 New Balance Recent Developments/Updates
6.9 P.w.minor
6.9.1 P.w.minor Corporation Information
6.9.2 P.w.minor Description and Business Overview
6.9.3 P.w.minor Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.9.4 P.w.minor Diabetic Shoes Product Portfolio
6.9.5 P.w.minor Recent Developments/Updates
6.10 Apis
6.10.1 Apis Corporation Information
6.10.2 Apis Description and Business Overview
6.10.3 Apis Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Apis Diabetic Shoes Product Portfolio
6.10.5 Apis Recent Developments/Updates
6.11 Apex
6.11.1 Apex Corporation Information
6.11.2 Apex Diabetic Shoes Description and Business Overview
6.11.3 Apex Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Apex Diabetic Shoes Product Portfolio
6.11.5 Apex Recent Developments/Updates
6.12 Dr. Zen
6.12.1 Dr. Zen Corporation Information
6.12.2 Dr. Zen Diabetic Shoes Description and Business Overview
6.12.3 Dr. Zen Diabetic Shoes Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Dr. Zen Diabetic Shoes Product Portfolio
6.12.5 Dr. Zen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetic Shoes Industry Chain Analysis
7.2 Diabetic Shoes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetic Shoes Production Mode & Process
7.4 Diabetic Shoes Sales and Marketing
7.4.1 Diabetic Shoes Sales Channels
7.4.2 Diabetic Shoes Distributors
7.5 Diabetic Shoes Customers
8 Diabetic Shoes Market Dynamics
8.1 Diabetic Shoes Industry Trends
8.2 Diabetic Shoes Market Drivers
8.3 Diabetic Shoes Market Challenges
8.4 Diabetic Shoes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Retail Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
